[1] Li Y, Yi S, Jiang W, et al.Exploring the relationship between different obesity metabolism indices and hyperuricemia in patients with hypertension and coronary heart disease[J]. Diabetes Metab Syndr Obes, 2024, 17: 3817-3832. [2] Yanai H, Adachi H, Hakoshima M, et al.Molecular biological and clinical understanding of the pathophysiology and treatments of hyperuricemia and its association with metabolic syndrome, cardiovascular diseases and chronic kidney disease[J]. Int J Mol Sci, 2021, 22(17): 9211. [3] 梁恒妙, 黄锶哲, 陈玉婷, 等. 健康体检人群血尿酸水平与胰岛素抵抗程度关系的研究[J]. 中国全科医学, 2025, 28(21): 2635-2642. [4] Gu X, Gao P, Shen Y, et al.Non-linear association between visceral adipose tissue area and serum uric acid concentration in US adults: Findings from NHANES 2011-2018[J]. BMC Public Health, 2025, 25(1): 1405. [5] Gui J, Li Y, Liu H, et al.Obesity-and lipid-related indices as a predictor of obesity metabolic syndrome in a national cohort study[J]. Front Public Health, 2023, 11: 1073824. [6] Gou R, Dou D, Tian M, et al.Association between triglyceride glucose index and hyperuricemia: A new evidence from China and the United States[J]. Front Endocrinol(Lausanne), 2024, 15: 1403858. [7] Kahaer M, Zhang B, Chen W, et al.Triglyceride glucose index is more closely related to hyperuricemia than obesity indices in the medical checkup population in Xinjiang, China[J]. Front Endocrinol(Lausanne), 2022, 13: 861760. [8] Zhou S, Yu Y, Zhang Z, et al.Association of obesity, triglyceride-glucose and its derivatives index with risk of hyperuricemia among college students in Qingdao, China[J]. Front Endocrinol(Lausanne), 2022, 13: 1001844. [9] 中华医学会风湿病学分会. 高危高尿酸血症药物降尿酸治疗专家共识(2025版)[J]. 中华医学杂志, 2025, 105(29): 2469-2482. [10] Bello-chavolla OY, Antonio-villa NE, Vargas-vázquez A, et al. Metabolic score for visceral fat(METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health[J]. Clin Nutr, 2020, 39(5): 1613-1621. [11] Feng X, Zhu J, Hua Z, et al.Comparison of obesity indicators for predicting cardiovascular risk factors and multimorbidity among the Chinese population based on ROC analysis[J]. Sci Rep, 2024, 14(1): 20942. [12] Simonavičius E, Perman-howe PR, Robson D, et al. Psychological distress, tobacco smoking and alcohol use: A population survey in Great Britain[J]. Addict Behav Rep, 2025, 21: 100604. [13] Robert Lourdes TG, Abd Hamid HA, Riyadzi MR, et al.Findings from a nationwide study on alcohol consumption patterns in an upper middle-income country[J]. Int J Environ Res Public Health, 2022, 19(14) :8851. [14] World Health Organization.WHO guidelines on physical activity and sedentary behaviour[M]. Geneva: World Health Organization, 2020. [15] Im PK, Kartsonaki C, Kakkoura MG, et al.Hyperuricemia, gout and the associated comorbidities in China: Findings from a prospective study of 0.5 million adults[J]. Lancet Reg Health West Pac, 2025, 58: 101572. [16] Wan Z, Song L, Hu L, et al.Temporal trends in hyperuricaemia among adults in Wuhan city, China, from 2010 to 2019: A cross-sectional study[J]. BMJ Open, 2021, 11(3): e043917. [17] 郑雯, 段绍杰, 陈佳良, 等. 体脂指标对高尿酸血症发生风险的预测价值[J]. 中国临床保健杂志, 2022, 25(6): 779-784. [18] 王迪, 王希, 尹福在, 等. 中国人内脏脂肪指数与2型糖尿病合并高尿酸血症的相关性研究[J]. 河北医药, 2022, 44(11): 1699-1701, 1705. [19] Zhang Q, Liu J, Zhang R, et al.TyG-WC index as a superior predictor of hyperuricemia risk in the hypertensive population: A prospective cohort study[J]. Diabetes Metab Syndr Obes, 2025, 18: 679-689. [20] Panlu K, Zhou Z, Huang L, et al.Associations between obesity and hyperuricemia combing mendelian randomization with network pharmacology[J]. Heliyon, 2024, 10(6): e27074. [21] 刘文清, 熊昱鹏, 李丽华, 等. 肥胖引发心血管疾病的相关机制研究进展[J]. 临床医学进展, 2023, 13(8): 12887-12893. [22] Fujii W, Yamazaki O, Hirohama D, et al.Gene-environment interaction modifies the association between hyperinsulinemia and serum urate levels through SLC22A12[J]. J Clin Invest, 2025, 135(10) :e186633. [23] Mandal AK, Leask MP, Sumpter NA, et al.Genetic and physiological effects of Insulin-Like Growth Factor-1 (IGF-1) on human urate homeostasis[J]. J Am Soc Nephrol, 2023, 34(3): 451-466. [24] 梁盛兴, 邹俐爱, 邱恒, 等. 1990—2021年中国归因于高BMI的慢性肾病疾病负担研究[J]. 卫生经济研究, 2025, 42(4): 42-46, 52. |